Pointing to the potential usefulness of genetic tests and therapeutics in patient care, the American Medical Association is calling for greater transparency and more standardized guidelines for payer coverage. READ MORE

Conferences

New guidelines from the National Comprehensive Cancer Network now advise that phsycians take a more active role in discussing sexual dysfunction with their patients. 

READ MORE

After a review of recent findings and US Food and Drug Administration approvals, the National Comprehensive Cancer Network has made some major changes to its guidelines for multiple myeloma. 

READ MORE

News

Pointing to the potential usefulness of genetic tests and therapeutics in patient care, the American Medical Association is calling for greater transparency and more standardized guidelines for payer coverage.

READ MORE

The National Comprehensive Cancer Network is partnering with a health care decision support company to integrate their clinical practice guidelines into a technological resource for point-of-care access and treatment recommendations.

READ MORE

A new clinical pathway has been designed and implemented to improve colon and rectal surgical procedures and enhance successful patient recovery.

READ MORE

McKesson Specialty Health and The US Oncology Network have expanded their agreement with the National Comprehensive Cancer Network to add five new disease states to Value Pathways.

READ MORE

Research in Review

The National Comprehensive Cancer Network agreed that ongoing monitoring and research regarding financial conflicts of interest at the interface of academia, medicine, and industry is critical, according a letter published in JAMA Oncology.

READ MORE

A new study that quantifies industry financial conflicts of interest (FCOIs) found that nearly nine out of 10 physicians and researchers who helped develop the National Comprehensive Network (NCCN) guidelines reported financial ties to the pharmaceutical and medical device industries. 

READ MORE

European Society of Cardiology has published a novel position paper tackling the problem of cardiac toxicity associated with anticancer therapies.

READ MORE

A team of researchers is recommending an overhaul of the process that determines which cancer drugs used off-label are reimbursed by federally-funded health insurance in the United States.  

READ MORE